I'd agree with that. Maybe that and some news on the first MACI procedure will be the tonic that reverses the very disappointing price action we've had since approval.
I know that's been mainly due the dilution but I think there is also a lack of confidence in management's ability to execute that's keeping buyers away. will need some good news on the execution front to change that.
I was in deep for approval, and got out with a much smaller profit than I expected. Might dip a toe or two but mostly watching until this company proves it can run a business.
News 
Market Data 
Discover 
